On March 3, 2021 CytRx Corporation (OTCQB: CYTR) ("CytRx" or the "Company"), a specialized biopharmaceutical company focused on research and development for the oncology and neurodegenerative disease categories, reported that Steven A. Kriegsman, Chairman and Chief Executive Officer of CytRx, is scheduled to participate in the following upcoming conferences (Press release, CytRx, MAR 3, 2021, View Source [SID1234576026]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

H.C. Wainwright Global Life Sciences Conference: March 9-10, 2021
Mr. Kriegsman will deliver a virtual presentation that will be available to conference participants on-demand beginning March 9, 2021.
Virtual 33rd Annual ROTH Conference: March 15-17, 2021
Mr. Kriegsman will deliver a virtual presentation that may be accessed on the News and Events page of the CytRx website beginning March 5, 2021.